Get Adobe Flash player

The first meeting will be on Thursday at 02.00 clock starts with a talk by Princeton University sociologist Robert Wuthnow, ‘No contradictions here. Science religion religion and culture of all reasonable options. ‘Wuthnow is Director of the Centre for the Study of Religion, and his work focuses on the links religion with business, politics, art and psychology. After his lecture, theoretical physicist Lawrence M. Krauss of Case Western reserve University, ‘Religion vs. Science present?

‘different branches of natural science have surprisingly different ways of thinking, ‘Dreyer says, ‘Our work. And our model – is only possible, though I am a physicist, I have been conducted in the state of research in the Department of Neuroscience and Pharmacology at the University of Copenhagen as soon as we are certain that the model is correct. We can begin applying it to dopamine diseases such as drug addiction and schizophrenia. ‘. Continue reading

The researchers studied the impact new and improved new and improved anthrax vaccine, and evaluated a number of vaccines properties that start, could provide immunity between 7 and 28 days. If vaccine was distributed along with antibiotics after an attack, the researchers calculated that vaccine occurs few more cases prevented if only rapid use of antibiotics compared. However, they found, if the 95 % 95 %, it could be the time that antibiotics up up 43 days, to reduce. A new and improved 80 % effective vaccine time time on antibiotics by up to 23 days. The vaccine may also prevent cases if an antibiotic-resistant strain of anthrax were used in the attack.

In a previous phase I study, NGX267 was well tolerated in single doses probably effective for treating memory and cognitive disturbances good.. I study,ines Therapeutics Initiates Phase I Multiple Dose Clinical Trial Of NGX267 for cognitive impairment associated with schizophreniaTorreyPines Therapeutics today announced that it is a phase initiated I multiple-dose study to assess the safety, tolerability and pharmacokinetics of NGX267 when for four days for four days to healthy male volunteers. A possible treatment for cognitive impairment with schizophrenia , respectively, is a functionally selective muscarinic receptor agonist. Continue reading